Cargando…
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
Extracellular vesicles (EVs) are increasingly being recognized as mediators of intercellular signaling via the delivery of effector molecules. Interestingly, certain types of EVs are also capable of inducing therapeutic responses. For these reasons, the therapeutic potential of EVs is a topic of int...
Autores principales: | Murphy, Daniel E., de Jong, Olivier G., Brouwer, Maarten, Wood, Matthew J., Lavieu, Grégory, Schiffelers, Raymond M., Vader, Pieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418170/ https://www.ncbi.nlm.nih.gov/pubmed/30872574 http://dx.doi.org/10.1038/s12276-019-0223-5 |
Ejemplares similares
-
Natural or Synthetic RNA Delivery: A Stoichiometric
Comparison of Extracellular Vesicles and Synthetic Nanoparticles
por: Murphy, Daniel E., et al.
Publicado: (2021) -
Drug Delivery with Extracellular Vesicles: From Imagination
to Innovation
por: de Jong, Olivier G., et al.
Publicado: (2019) -
Lack of involvement of CD63 and CD9 tetraspanins in the extracellular vesicle content delivery process
por: Tognoli, Maria Laura, et al.
Publicado: (2023) -
Microbubbles-Assisted Ultrasound Triggers the Release of Extracellular Vesicles
por: Yuana, Yuana, et al.
Publicado: (2017) -
Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approach
por: Kooijmans, Sander A. A., et al.
Publicado: (2018)